Clarivate logo

Clarivate

CLVT | NYSE
Chart Builder DCF Calculator
$1.93
+$0.04 (+2.12%)
At close: Sep 21, 2026, 4:00 PM ET
$1.92
-$0.01 (-0.52%)
Pre-market: Sep 22, 2026, 4:44 AM ET

Company Profile

Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.

Key Executives

Name Position
Matitiahu Shem Tov Chief Executive Officer & Director
Jonathan Collins Executive Vice President & Chief Financial Officer
Michael Easton Executive Vice President & Chief Financial Officer
William E. Graff Executive Vice President & Chief Information Officer
Bar Veinstein President of Academia & Government
Darien Krimmert Senior Vice President & Head of People
Gwenan White Senior Vice President of Communications & Brand
Henry Levy President of Life Sciences & Healthcare
John Doulamis Senior Vice President & General Counsel
Mark J. Donohue Vice President of Investor Relations
Maroun S. Mourad Advisor
Matthew Lisowski Senior VP & Chief Accounting Officer
Tabita Andersson Senior Vice President of Communications & Brand

Latest SEC Filings

Date Type Title
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 14, 2026 3 Filing
Aug 10, 2026 4 Filing
Aug 05, 2026 4 Filing
Jul 29, 2026 8-K Current Report
Jul 29, 2026 10-Q Quarterly Report
Jul 29, 2026 8-K Current Report
Jul 06, 2026 8-K Current Report
View All SEC Filings
Clarivate
Clarivate logo
Country United Kingdom
IPO Date Oct 28, 2018
Industry Information Technology Services
Sector Technology
Employees 12,000
CEO Matitiahu Shem Tov

Contact Details

70 St. Mary Axe London, GL EC3A 8BE United Kingdom

Stock Details

Ticker Symbol CLVT
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001764046
CUSIP Number G21810109
ISIN Number JE00BJJN4441
SIC Code 7374

© 2026 bestshares.com. All rights reserved.